Key Points
Alliance Global maintains Buy rating on STRW with $16 price target.
STRW revenue grew 32%, net income surged 85% year-over-year.
Meyka AI rates STRW B+ with buy recommendation based on fundamentals.
Five analysts rate Buy, one Hold; stock offers 24.6% upside to target.
Analyst ratings matter when you’re tracking healthcare REITs. Alliance Global Partners maintained its Buy rating on Strawberry Fields REIT (STRW) while raising the price target to $16 from $15 on May 8, 2026. This analyst rating maintained decision reflects confidence in the company’s portfolio of 79 skilled nursing facilities across nine states. The stock trades at $12.82, down 1% today, with a market cap of $177 million. Meyka AI rates STRW with a grade of B+, suggesting a buy recommendation based on comprehensive market analysis.
What the Analyst Rating Maintained Means for STRW
Understanding the Rating Action
Alliance Global Partners kept its Buy rating intact while boosting the price target by $1 per share. This analyst rating maintained stance signals the firm sees value in STRW despite recent market weakness. The stock fell 0.13 points to close at $12.82, but the higher price target suggests upside potential of roughly 24.6% from current levels. The company operates a diversified portfolio generating steady revenue from healthcare operators.
Why the Price Target Increased
The price target raise reflects improved fundamentals in STRW’s healthcare property portfolio. Strawberry Fields REIT owns 10,426 licensed beds across skilled nursing and post-acute care facilities. Revenue grew 32.4% year-over-year, while net income surged 85%. Operating cash flow jumped 51.8%, demonstrating strong cash generation. These metrics justify the analyst’s confidence in the $16 target, even as the broader market digests earnings.
STRW’s Financial Performance and Meyka Grade
Strong Cash Flow and Dividend Yield
Strawberry Fields REIT generated $6.64 per share in free cash flow trailing twelve months. The dividend yield stands at 4.87%, attractive for income investors. Earnings per share reached $0.60, with a P/E ratio of 22.05. The company maintains a healthy balance sheet with minimal debt relative to market cap. Operating margins exceed 54%, showing efficient property management and tenant relationships.
Meyka AI’s B+ Grade Explained
Meyka AI rates STRW with a grade of B+, factoring in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. This grade reflects solid fundamentals but acknowledges valuation concerns and sector headwinds. The rating suggests a buy recommendation for investors seeking healthcare real estate exposure. These grades are not guaranteed and we are not financial advisors. The STRW stock page provides real-time updates on analyst coverage and price forecasts.
Analyst Consensus and Market Outlook
Broader Analyst Coverage
Five analysts rate STRW as Buy, while one rates it Hold. The consensus rating is 3.0 out of 5, indicating moderate bullish sentiment. No analysts rate the stock as Sell or Strong Sell. This broad support suggests the market recognizes STRW’s value proposition in the healthcare REIT space. Alliance Global’s maintained rating aligns with this consensus view.
Technical and Valuation Signals
The stock trades at 1.12x sales and 22.8x earnings, reasonable multiples for a healthcare REIT with growing cash flows. Year-to-date performance shows 0.99% gains, while the 52-week range spans $9.46 to $14.00. Volume averaged 27,998 shares daily, with today’s trading at 24,865 shares. The technical setup shows RSI at 58.5, suggesting neutral momentum. Meyka AI’s forecasts project $13.32 for 2026 and $15.62 by 2029.
Why Healthcare REITs Matter in Your Portfolio
Sector Dynamics and STRW’s Position
Healthcare REITs provide stable income and inflation protection through long-term tenant leases. STRW operates in the REIT – Healthcare Facilities sector, managing skilled nursing and post-acute care properties. The company’s 79-property portfolio spans nine states, reducing geographic concentration risk. Tenant diversification and long-term contracts support predictable cash flows. This defensive positioning appeals to income-focused investors.
Growth Catalysts Ahead
Strawberry Fields REIT benefits from aging demographics and rising demand for skilled nursing beds. The company’s 85% net income growth reflects operational leverage and pricing power. Management’s focus on quality properties and experienced operators strengthens competitive positioning. The maintained Buy rating and raised price target suggest analysts see room for further appreciation as the market recognizes these growth drivers.
Final Thoughts
Alliance Global Partners’ maintained Buy rating and $16 price target on Strawberry Fields REIT reflect confidence in the company’s healthcare property portfolio and financial trajectory. STRW’s 32% revenue growth, 85% net income surge, and 52% operating cash flow increase demonstrate operational strength. The B+ Meyka grade and five-analyst buy consensus support the bullish case. At $12.82, the stock trades 24.6% below the new price target, offering potential upside for healthcare REIT investors. The maintained rating signals stability, while the higher target acknowledges improving fundamentals. Investors should monitor quarterly earnings and occupancy rates as key metrics for future performance.
FAQs
Alliance Global Partners maintained its Buy rating while raising the price target to $16 from $15, signaling confidence in STRW’s healthcare property portfolio and cash flow generation despite market volatility.
Strong financial performance—32% revenue growth, 85% net income growth, and 52% operating cash flow increase—justified the $1 increase to $16, suggesting upside potential from current price levels.
Meyka AI rates STRW with a B+ grade, suggesting a buy recommendation based on S&P 500 benchmarks, sector performance, financial growth, and analyst consensus. These grades are not guaranteed.
Five analysts rate STRW as Buy, one as Hold, and none as Sell. The consensus rating of 3.0 out of 5 reflects moderate bullish sentiment and market recognition of STRW’s healthcare real estate value.
STRW’s 4.87% dividend yield attracts income investors seeking stable returns. Healthcare REITs distribute most taxable income to shareholders, and this high yield reflects strong cash generation from 79 skilled nursing facilities.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)